Global Interstitial Cystitis Market to Value $427 Million - Number of IC Cases to Reach 197,086 by 2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast - 2023" drug pipelines to their offering.

The report provides an overview of the disease and global market trends of the Interstitial Cystitis for the seven major markets i.e. United States, Europe (France, Germany, Italy, Spain, UK) and Japan. The report covers the therapeutics market revenue, treatment practice and Interstitial Cystitis forecasted market share from 2017 to 2023 segmented by seven major markets.

In addition, the report also includes global forecast of epidemiology of Interstitial Cystitis till 2023. Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems. Current studies estimate that 2.7% to 6.5% of women in the United States have symptoms consistent with a diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS). PBS/IC is more common in women, with a female/male ratio that ranges from 5:1 to 10:1 and the Median age at diagnosis is 42 to 46 yr old whereas men are diagnosed at a younger age.

According to research, the Interstitial Cystitis market for 7MM is estimated to be USD 427.2 Million by 2023. The number of Incident Probable IC cases is expected to reach 197,086 cases in 2023.

Scope of the Report:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Interstitial Cystitis market.
  • Organize sales and marketing efforts by identifying the best opportunities for Interstitial Cystitis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • To understand the future market competition in the global Interstitial Cystitis market and Insightful review of the key market drivers and barriers.
  • To understand the regulatory scenario in major markets.
  • The report also covers the detailed global historical and forecasted Interstitial Cystitis market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/rs3sw4/interstitial

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Urological Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Urological Disorders Drugs